31
Participants
Start Date
April 20, 2021
Primary Completion Date
September 30, 2021
Study Completion Date
October 31, 2021
Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)
The antibody level will be measured by the above mentioned methods. The trial drugs are not used but the vaccine that included in National Immunization Program for COVID-19 in Korea will be used for the study.
Hanyang University Seoul Hospital, Seoul
Seegene Medical Foundation
UNKNOWN
Hanyang University Seoul Hospital
OTHER